These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 23984984

  • 1. Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.
    Krasnov GS, Dmitriev AA, Lakunina VA, Kirpiy AA, Kudryavtseva AV.
    Expert Opin Ther Targets; 2013 Oct; 17(10):1221-33. PubMed ID: 23984984
    [Abstract] [Full Text] [Related]

  • 2. Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II.
    Bryan N, Raisch KP.
    Biosci Rep; 2015 Apr 24; 35(3):. PubMed ID: 26182367
    [Abstract] [Full Text] [Related]

  • 3. Disruption of the hexokinase-VDAC complex for tumor therapy.
    Galluzzi L, Kepp O, Tajeddine N, Kroemer G.
    Oncogene; 2008 Aug 07; 27(34):4633-5. PubMed ID: 18469866
    [Abstract] [Full Text] [Related]

  • 4. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.
    Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V.
    Biochem J; 2004 Jan 15; 377(Pt 2):347-55. PubMed ID: 14561215
    [Abstract] [Full Text] [Related]

  • 5. FV-429 induces apoptosis and inhibits glycolysis by inhibiting Akt-mediated phosphorylation of hexokinase II in MDA-MB-231 cells.
    Zhou Y, Lu N, Qiao C, Ni T, Li Z, Yu B, Guo Q, Wei L.
    Mol Carcinog; 2016 Sep 15; 55(9):1317-28. PubMed ID: 26258875
    [Abstract] [Full Text] [Related]

  • 6. Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro.
    Wang K, Fan H, Chen Q, Ma G, Zhu M, Zhang X, Zhang Y, Yu J.
    Anticancer Drugs; 2015 Jan 15; 26(1):15-24. PubMed ID: 25229889
    [Abstract] [Full Text] [Related]

  • 7. Hexokinase inhibits flux of fluorescently labeled ATP through mitochondrial outer membrane porin.
    Perevoshchikova IV, Zorov SD, Kotova EA, Zorov DB, Antonenko YN.
    FEBS Lett; 2010 Jun 03; 584(11):2397-402. PubMed ID: 20412805
    [Abstract] [Full Text] [Related]

  • 8. VDAC electronics: 1. VDAC-hexo(gluco)kinase generator of the mitochondrial outer membrane potential.
    Lemeshko VV.
    Biochim Biophys Acta; 2014 May 03; 1838(5):1362-71. PubMed ID: 24412217
    [Abstract] [Full Text] [Related]

  • 9. Gomisin J inhibits the glioma progression by inducing apoptosis and reducing HKII-regulated glycolysis.
    Li R, Yang W.
    Biochem Biophys Res Commun; 2020 Aug 13; 529(1):15-22. PubMed ID: 32560813
    [Abstract] [Full Text] [Related]

  • 10. ATP produced by oxidative phosphorylation is channeled toward hexokinase bound to mitochondrial porin (VDAC) in beetroots (Beta vulgaris).
    Alcántar-Aguirre FC, Chagolla A, Tiessen A, Délano JP, González de la Vara LE.
    Planta; 2013 Jun 13; 237(6):1571-83. PubMed ID: 23503782
    [Abstract] [Full Text] [Related]

  • 11. Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives.
    Reina S, De Pinto V.
    Curr Med Chem; 2017 Jun 13; 24(40):4447-4469. PubMed ID: 28554318
    [Abstract] [Full Text] [Related]

  • 12. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer.
    Pedersen PL.
    J Bioenerg Biomembr; 2008 Jun 13; 40(3):123-6. PubMed ID: 18780167
    [Abstract] [Full Text] [Related]

  • 13. [Voltage-dependent anion channel and hematological malignancies].
    Sun Y, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb 13; 18(1):255-61. PubMed ID: 20137159
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines.
    Sucu BO, Ipek OS, Kurtulus SO, Yazici BE, Karakas N, Guzel M.
    Bioorg Chem; 2019 Oct 13; 91():103146. PubMed ID: 31377389
    [Abstract] [Full Text] [Related]

  • 15. Role of Hexokinase and VDAC in Neurological Disorders.
    Rosa JC, César MC.
    Curr Mol Pharmacol; 2016 Oct 13; 9(4):320-331. PubMed ID: 26758954
    [Abstract] [Full Text] [Related]

  • 16. VDAC electronics: 5. Mechanism and computational model of hexokinase-dependent generation of the outer membrane potential in brain mitochondria.
    Lemeshko VV.
    Biochim Biophys Acta Biomembr; 2018 Dec 13; 1860(12):2599-2607. PubMed ID: 30291922
    [Abstract] [Full Text] [Related]

  • 17. Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII.
    Guo Y, Wei L, Zhou Y, Lu N, Tang X, Li Z, Wang X.
    Free Radic Biol Med; 2020 Jan 13; 146():119-129. PubMed ID: 31669347
    [Abstract] [Full Text] [Related]

  • 18. Application of 2D BN/SDS-PAGE coupled with mass spectrometry for identification of VDAC-associated protein complexes related to mitochondrial binding sites for type I brain hexokinase.
    Crepaldi CR, Vitale PA, Tesch AC, Laure HJ, Rosa JC, de Cerqueira César M.
    Mitochondrion; 2013 Nov 13; 13(6):823-30. PubMed ID: 23719229
    [Abstract] [Full Text] [Related]

  • 19. VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.
    Fang D, Maldonado EN.
    Adv Cancer Res; 2018 Nov 13; 138():41-69. PubMed ID: 29551129
    [Abstract] [Full Text] [Related]

  • 20. Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding.
    Quach CH, Jung KH, Lee JH, Park JW, Moon SH, Cho YS, Choe YS, Lee KH.
    PLoS One; 2016 Nov 13; 11(8):e0159529. PubMed ID: 27479079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.